InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,266.95
(
-0.74%
)
US TECH 100
18,166.00
(
-1.20%
)
Dow Jones
38,441.54
(
-1.06%
)
Brent Oil
83.38
(
-1.13%
)
Bitcoin
67,609.44
(
-0.99%
)
Post# of 3834
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Chess Master

Send PM Follow Ignore
Followers 41
Posts 1440
Boards Moderated 0
Alias Born 04/05/2009

Chess Master

Re: gss2003 post# 2668

Friday, 01/20/2017 11:33:59 AM

Friday, January 20, 2017 11:33:59 AM

Post# of 3834
Looks like a swag. If you do your own analysis. Keytruda seems to be doing about 300 - 500 mil per quarter and they keep adding indications. So why wouldn't a drug in combination that doubles the potency be worth the same amount? So 1.0 bil seem way too low to me.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM

Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM

HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!